1. Home
  2. KMDA

KMDA

Kamada Ltd.

Logo Kamada Ltd.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Founded: 1990 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 292.0M IPO Year: N/A
Target Price: $11.00 AVG Volume (30 days): 22.4K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 0.15 EPS Growth: N/A
52 Week Low/High: $4.08 - $6.53 Next Earning Date: 05-15-2024
Revenue: $142,519,000 Revenue Growth: 10.19%
Revenue Growth (this year): 13.23% Revenue Growth (next year): 23.29%

Share on Social Networks: